Cargando…
Polycytidine tract deletion from microRNA-detargeted oncolytic Mengovirus optimizes the therapeutic index in a murine multiple myeloma model
Mengovirus is an oncolytic picornavirus whose broad host range allows for testing in immunocompetent cancer models. Two pathogenicity-ablating approaches, polycytidine (polyC) tract truncation and microRNA (miRNA) targets insertion, eliminated the risk of encephalomyocarditis. To investigate whether...
Autores principales: | Penza, Velia, Maroun, Justin W., Nace, Rebecca A., Schulze, Autumn J., Russell, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800256/ https://www.ncbi.nlm.nih.gov/pubmed/36619293 http://dx.doi.org/10.1016/j.omto.2022.11.006 |
Ejemplares similares
-
MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy
por: Ruiz, Autumn J., et al.
Publicado: (2016) -
MicroRNA-detargeting proves more effective than leader gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model
por: Suryawanshi, Yogesh R., et al.
Publicado: (2021) -
The long-lasting enigma of polycytidine (polyC) tract
por: Penza, Velia, et al.
Publicado: (2021) -
Collateral Lethal Effects of Complementary Oncolytic Viruses
por: Maroun, Justin W., et al.
Publicado: (2020) -
Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5
por: Nguyen, Tien V., et al.
Publicado: (2017)